• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感疫苗:病毒体概念

Influenza vaccines: the virosome concept.

作者信息

Wilschut Jan

机构信息

Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Immunol Lett. 2009 Feb 21;122(2):118-21. doi: 10.1016/j.imlet.2008.11.006. Epub 2008 Dec 25.

DOI:10.1016/j.imlet.2008.11.006
PMID:19100779
Abstract

Influenza virosomes are virus-like particles, which retain the cell binding and membrane fusion properties of the native virus, but lack the viral genetic material. These functional characteristics of influenza virosomes form the basis for their immunogenicity. First, the repetitive arrangement of the major viral envelope glycoprotein, haemagglutinin, on the virosomal surface mediates a co-operative interaction with Ig receptors on B lymphocytes, stimulating strong antibody responses. In addition, virosomes interact efficiently with antigen-presenting cells, such as dendritic cells, resulting in activation of T lymphocytes and induction of a balanced Th1/Th2 response. Also, as a result of fusion of the virosomes with the endosomal membrane, virosome-encapsulated antigens gain access to the MHC class I presentation pathway, thus priming cytotoxic T lymphocyte (CTL) activity. Finally, virosomes represent an excellent platform for inclusion of lipophilic adjuvants for further improvement of the quality and quantity of virosome-induced immune responses.

摘要

流感病毒体是病毒样颗粒,保留了天然病毒的细胞结合和膜融合特性,但缺乏病毒遗传物质。流感病毒体的这些功能特性构成了其免疫原性的基础。首先,主要病毒包膜糖蛋白血凝素在病毒体表面的重复排列介导了与B淋巴细胞上Ig受体的协同相互作用,刺激强烈的抗体反应。此外,病毒体与抗原呈递细胞(如树突状细胞)有效相互作用,导致T淋巴细胞活化并诱导平衡的Th1/Th2反应。而且,由于病毒体与内体膜融合,病毒体包裹的抗原得以进入MHC I类呈递途径,从而启动细胞毒性T淋巴细胞(CTL)活性。最后,病毒体是包含亲脂性佐剂的极佳平台,可进一步提高病毒体诱导的免疫反应的质量和数量。

相似文献

1
Influenza vaccines: the virosome concept.流感疫苗:病毒体概念
Immunol Lett. 2009 Feb 21;122(2):118-21. doi: 10.1016/j.imlet.2008.11.006. Epub 2008 Dec 25.
2
The virosome concept for influenza vaccines.流感疫苗的病毒体概念。
Vaccine. 2005 Jul 8;23 Suppl 1:S26-38. doi: 10.1016/j.vaccine.2005.04.026.
3
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.病毒体介导的蛋白质抗原体内递送:I类主要组织相容性复合体限制的细胞毒性T淋巴细胞活性的有效诱导
Vaccine. 2005 Jan 26;23(10):1232-41. doi: 10.1016/j.vaccine.2004.09.002.
4
Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.将脱毒脂多糖佐剂LpxL1掺入H5N1流感病毒体中可提高疫苗的免疫原性。
Vaccine. 2009 Feb 5;27(6):947-55. doi: 10.1016/j.vaccine.2008.11.046. Epub 2008 Dec 4.
5
Influenza virosomes in vaccine development.疫苗研发中的流感病毒体
Methods Enzymol. 2003;373:74-91. doi: 10.1016/S0076-6879(03)73005-5.
6
Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.负载肽的嵌合流感病毒体用于在体内高效诱导细胞毒性T细胞
Int Immunol. 2005 Jun;17(6):695-704. doi: 10.1093/intimm/dxh249. Epub 2005 Apr 20.
7
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.针对病毒体佐剂化H9N2禽流感疫苗的抗体和T细胞反应:不同额外佐剂的影响
Vaccine. 2008 Jul 4;26(29-30):3640-6. doi: 10.1016/j.vaccine.2008.04.071. Epub 2008 May 15.
8
The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.既往免疫对流感病毒体诱导细胞毒性T淋巴细胞活性能力的影响。
Vaccine. 2008 May 2;26(19):2314-21. doi: 10.1016/j.vaccine.2008.03.002. Epub 2008 Mar 19.
9
Influenza virosomes: a flu jab for malaria?流感病毒体:一种用于疟疾的流感疫苗?
Trends Parasitol. 2008 Sep;24(9):382-5. doi: 10.1016/j.pt.2008.06.002. Epub 2008 Aug 5.
10
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.体外将HLA-A0201限制性、黑色素瘤相关的L(27)Melan-A/MART-1(26-35)肽包裹于病毒体中可有效诱导杀肿瘤细胞毒性T淋巴细胞。
Vaccine. 2005 Dec 1;23(48-49):5572-82. doi: 10.1016/j.vaccine.2005.07.099. Epub 2005 Aug 15.

引用本文的文献

1
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines.分析已获批的 COVID-19 疫苗对奥密克戎变异株的保护效力和通用疫苗的前景。
Front Immunol. 2023 Nov 27;14:1294288. doi: 10.3389/fimmu.2023.1294288. eCollection 2023.
2
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.非侵入性疫苗:制剂和疫苗佐剂方面的挑战
Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114.
3
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine.
免疫小鼠多价病毒体流感疫苗的免疫谱。
Virol J. 2023 Aug 21;20(1):187. doi: 10.1186/s12985-023-02158-0.
4
A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs.多价病毒样流感疫苗可诱导猪产生广泛的细胞和体液免疫。
Virol J. 2023 Aug 16;20(1):181. doi: 10.1186/s12985-023-02153-5.
5
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.疫苗佐剂概述:当前证据与未来展望
Vaccines (Basel). 2022 May 22;10(5):819. doi: 10.3390/vaccines10050819.
6
Virus-like particle-based vaccines for animal viral infections.用于动物病毒感染的基于病毒样颗粒的疫苗。
Inmunologia. 2013 Jul-Sep;32(3):102-116. doi: 10.1016/j.inmuno.2012.08.002. Epub 2012 Oct 26.
7
IC-Tagging methodology applied to the expression of viral glycoproteins and the difficult-to-express membrane-bound IGRP autoantigen.IC-Tagging 方法在病毒糖蛋白表达和难以表达的膜结合 IGRP 自身抗原中的应用。
Sci Rep. 2018 Nov 2;8(1):16286. doi: 10.1038/s41598-018-34488-3.
8
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy.流感疫苗使用的适宜性:来自意大利最新季节的建议。
Hum Vaccin Immunother. 2018 Mar 4;14(3):699-705. doi: 10.1080/21645515.2017.1388480. Epub 2017 Dec 1.
9
Development of a stable liquid formulation of live attenuated influenza vaccine.减毒活流感疫苗稳定液体制剂的研发。
Vaccine. 2016 Jul 12;34(32):3676-83. doi: 10.1016/j.vaccine.2016.04.074. Epub 2016 May 4.
10
Engraftment of plasma membrane vesicles into liposomes: A new method for designing of liposome-based vaccines.质膜囊泡向脂质体的植入:一种基于脂质体的疫苗设计新方法。
Iran J Basic Med Sci. 2014 Oct;17(10):772-8.